The nation of Zimbabwe has declined a significant American healthcare agreement worth $367m (£272m) over five years over Washington's insistence on confidential data.
This rejection came to light after a government memo from December was disclosed, which showed Head of State Emmerson Mnangagwa deemed the agreement was "unbalanced".
An official spokesman later clarified that the US was requesting health data for research and profit while was not willing to guarantee the resulting advantages from any future vaccines.
"We will now turn to the challenging and unfortunate task of winding down our health assistance in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.
Her embassy noted the US had provided more than $1.9bn for health programmes to Zimbabwe during the past two decades.
A doctors' association in Zimbabwe has urged continued dialogue to find a deal acceptable to both sides so the country's critical HIV programme can continue.
Broader Background
This rejection comes after a comparable situation in neighbouring Kenya, where a court halted a related health funding agreement after legal challenges were filed about the security of Kenyans' health data.
After returning to the presidency recently, US President Donald Trump has slashed overseas assistance and closed the US Agency for International Development (USAID).
USAID had administered assistance for the American government, but Trump claimed its expenditure was "inefficient" and his government was seeking direct bilateral deals to boost openness and accountability.
According to reports, 16 nations in Africa have so far agreed to these new health pacts, representing over $18.3bn in new funding.
Details of the Declined Deal
The money for Zimbabwe was intended to gone towards "tackling HIV/Aids, TB, malaria, maternal and child health, and disease outbreak preparedness.
"We are confident this cooperation would have delivered immense benefits for Zimbabwean communities, particularly the 1.2 million presently receiving antiretroviral therapy through US-supported initiatives," Tremont added.
However, official spokesman Nick Mangwana said the proposed deal was "unfair".
"Our nation was requested to surrender its biological resources and data for a long time, without any equivalent guarantee of benefiting from any medical innovations – like vaccines, diagnostics, or treatments – that could be developed from that provided information," he stated.
"In essence, our country would provide the basic resources for medical research with no certainty that the resulting innovations would be accessible to our citizens should a future pandemic arise."
National Interest and Global Health
He also pointed out that the US's withdrawal from the World Health Organization (WHO) and its push of bilateral deals were upending frameworks previously established via the global health agency.
Mangwana gave as an example its Pathogen Access and Benefit Sharing system created to manage future global health emergencies.
"This mechanism is designed to ensure that when a nation provides its information, the resulting advantages – including medicines and cures – are shared equitably, not monopolised exclusively by those with the funds to create them."
The government's concerns over the US deal "must not be interpreted as anti-American sentiment," he added.
"We welcome continued dialogue with our US partners on how subsequent co-operation could be arranged in a way that honours the sovereignty and interests of each country."
Health Experts Response
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it acknowledged the government's concerns, but urged that talks should continue considering a large portion of the country's Aids initiatives relied on foreign aid.
"Where specific concerns exist, such as those involving data governance or agreement terms, these can frequently be resolved through detailed discussion and mutually agreed protections," it added.
This impasse emphasises the complex challenges between receiving much-needed foreign assistance and protecting national sovereignty in an ever more interconnected world.